Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2)

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2)

 EDITORIAL NEW TRACERS TO THE CLINIC: TRANSLATIONAL STUDIES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):133-4

New tracers to the clinic

Marion de JONG *


 SPECIAL ARTICLE NEW TRACERS TO THE CLINIC: TRANSLATIONAL STUDIES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):135-44

European regulations for the introduction of novel radiopharmaceuticals in the clinical setting

Clemens DECRISTOFORO *, Ivan PENUELAS, Marianne PATT, Sergio TODDE


 REVIEW NEW TRACERS TO THE CLINIC: TRANSLATIONAL STUDIES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):145-52

Preclinical in vivo cancer, straightway to patients?

Marion de JONG *, Stephen MATHER, Theodosia MAINA


 REVIEW NEW TRACERS TO THE CLINIC: TRANSLATIONAL STUDIES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):153-67

Radiolabeled peptides: current and new perspectives

Marta OPALINSKA *, Alicja HUBALEWSKA-DYDEJCZYK, Anna SOWA-STASZCZAK


 REVIEW NEW TRACERS TO THE CLINIC: TRANSLATIONAL STUDIES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):168-80

Radiolabeled prostate-specific membrane antigen small-molecule inhibitors

Leon WILL, Ida SONNI, Klaus KOPKA, Clemens KRATOCHWIL, Frederik L. GIESEL *, Uwe HABERKORN


 REVIEW NEW TRACERS TO THE CLINIC: TRANSLATIONAL STUDIES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):181-204

Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: an overview

Rubel CHAKRAVARTY *, Shreya GOEL, Ashutosh DASH, Weibo CAI


 ORIGINAL ARTICLE 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):205-15

Staging of locally advanced breast cancer and the prediction of response to neoadjuvant chemotherapy: complementary role of scintimammography and 18F-FDG PET/CT

Laura EVANGELISTA *, Anna R. CERVINO, Silvia MICHIELETTO, Tania SAIBENE, Enrico ORVIETO, Fernando BOZZA, Cristina GHIOTTO


 ORIGINAL ARTICLE 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):216-31

Therapeutic schemes in 177Lu and 90Y-PRRT: radiobiological considerations

Anna SARNELLI *, Francesco GUERRIERO, Francesca BOTTA, Mahila FERRARI, Lidia STRIGARI, Lisa BODEI, Vincenzo D’ERRICO, Elisa GRASSI, Federica FIORONI, Giovanni PAGANELLI, Roberto ORECCHIA, Marta CREMONESI


 REVIEW 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):232-46

Clinical application of FDG-PET/CT in metastatic infections

Ilse J. KOUIJZER *, Fidel J. VOS, Chantal P. BLEEKER-ROVERS, Wim J. OYEN


top of page